ATLANTA – Jennifer Kauffman, NP-C and CEO of Vein Institute & Medi Spa, Inc. in Warsaw, was recently selected and recognized among the nation’s leading cosmetic injectors and was chosen to join an elite group to receive early training on the latest FDA-approved filler, Juvederm Voluma™ XC in Atlanta. The training was lead under the direction of Dr. Mauricio de Maio, MD of Brazil. He is a world-renowned plastic surgeon who has extensive experience using Voluma.
Voluma XC, approved by the FDA in October, is an injectable gel filler for the treatment of age related volume loss in the cheek area. Results are long-lasting – up to two years in most cases. Its longevity is longer than most fillers, lasting up to two years in the clinical trials. At two years, 76 percent of patients were still satisfied with their Voluma results. It was 90 percent satisfaction at six months. Voluma has been used in Europe since 2005.
“I am so excited about Voluma because this new technology gives our patients natural, long-lasting results to restore cheeks and cheekbones that have started to flatten and sag with age,” Kauffman said. “We are always striving to bring the latest procedures and treatments to our patients in northern Indiana. This new product will help delay the need for surgical intervention, which can have longer periods of downtime and time off of work.”
Juvederm Voluma XC is made by Allergan, the pharmaceutical company known for Botox® Cosmetic and Juvederm® XC. For more information, visit www.juvederm.com/views/voluma/ or to schedule a complimentary consultation, call the Vein Institute & Medi Spa at 574-267-1900 or visit www.veinmedicalspa.com